A higher dose of either drug meant a 6.6% weight drop versus 3.5% for a lower dose. Those taking the drug for obesity experienced a 5.9% decrease in weight versus 3.2% for diabetes treatment.

There’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, manage obstructive sleep apnea, and more. But as more people use these ...

People considering weight-loss medications might wonder which one works best, and first-of-its-kind research points to an answer. A new study published in the New England Journal of Medicine ...

Both drugs led to substantial weight loss, but Mounjaro's 20% weight reduction, after 72 weeks of treatment, exceeded the 14% from Wegovy. More in Health A 51-year-old says she's in the best shape ...

But it’s worth mentioning that when Wegovy was tested at a much higher dose of 7.2 milligrams, people lost around 20.7% of their body weight. That’s a big jump from the 13.7% seen with the ...

In key secondary endpoints, Zepbound was superior across all weight reduction targets with 64.6% of participants treated with Zepbound achieving at least 15.0% weight loss compared to 40.1% on Wegovy.

Hair loss also correlated with amount of weight lost, as more participants who lost 20% or more of their body weight experienced hair loss than those who lost less than 20% (5.3% vs 2.5%).

Both drugs led to substantial weight loss, but Mounjaro's 20% weight reduction, after 72 weeks of treatment, exceeded the 14% from Wegovy, according to the trial's findings.

There’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, manage obstructive sleep apnea, and more.But as more people use these ...